AABB2025: AABB Welcomes Additional Organizations to Biotherapies Pavilion

AABB is pleased to welcome several organizations to the Biotherapies Pavilion at the 2025 AABB Annual Meeting: Accellix, J&J Innovative Medicine and Terumo Blood and Cell Technologies.

These are among several innovative companies and organizations participating in this year’s pavilion, a dedicated networking space in the Exhibit Hall that offers curated opportunities to connect with key audiences and engage with the broader AABB Annual Meeting community. It’s also home to expert-led open-mic conversations focusing on the most pressing topics in biotherapies.

Additional participants include BBG Advanced Therapies, Charles River Laboratories, Eurofins CellTx, FerroBio Technologies, Save the Cord Foundation, Versiti and Vitalant.

To spotlight participating organizations, AABB spoke with Trevor Smith, MS, MBA, senior marketing manager for cell and gene therapy at Terumo BCT, and Charis Ober, founder and executive director at Save The Cord, about their organizations and the changing landscape of biotherapies.

Biotherapies companies interested in securing a networking table or connection package at this year’s pavilion can find additional details in the Biotherapies Pavilion brochure.